Alternative Investment Losses with Kalos Capital, Inc. Broker Kristian Finfrock?

Kalos Capital Inc. logo

Kalos Capital, Inc. broker Kristian Finfrock (CRD# 5421676) is accused of unsuitable alternative investment losses. He has been registered with Kalos Capital, Inc. in Evansville, Wisconsin since 2012. 

Alternative investments do not fall into a conventional investment category, such as stocks, bonds, and cash. Most alternative investments are complex in nature and pose a degree of risk. They are typically held by high-net-worth investors or institutional investors.

Kristian Finfrock Customer Complaints

He has been the subject of three customer complaints between 2020 and 2021, according to his CRD report:

December 2021. “Breach of fiduciary duty, breach of contract and negligence, negligent supervision, fraudulent inducement to hold investment, violation of FINRA/NYSE rules, and violation of the securities laws, including the Wisconsin Securities Act.” The customer is seeking $100,000 in damages. 

May 2021. “Unsuitable recommendations to concentrate Claimants’ accounts, including IRA accounts, in illiquid, high commission private placement investments. The case was settled for $35,000.

January 2020. “Unsuitable investments.” The customer sought $500,000 in damages and the case was settled for $100,000. The complaint was regarding alternative investments. 

Pursuant to FINRA Rules, member firms are responsible for supervising a broker’s activities during the time the broker is registered with the firm. Therefore, Kalos Capital, Inc. may be liable for investment or other losses suffered by Kristian Finfrock’s customers.

Erez Law represents investors in the United States for claims against brokers and brokerage firms for wrongdoing. If you have experienced investment losses, please call us at 888-840-1571 or complete our contact form for a free consultation. Erez Law is a nationally recognized law firm representing individuals, trusts, corporations and institutions in claims against brokerage firms, banks and insurance companies on a contingency fee basis.